Vera Therapeutics Inc. (VERA)
NASDAQ: VERA
· Real-Time Price · USD
21.55
0.28 (1.32%)
At close: Aug 15, 2025, 3:59 PM
21.21
-1.58%
After-hours: Aug 15, 2025, 07:17 PM EDT
Vera Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 563K | n/a | -952K | -1.59M | -1.59M | -1.59M | -1.14M | -506K | -506K | -506K | 9K | 41K | 100K | 150K | 176K | 144K | 85K | 35K |
Gross Profit | -563K | n/a | 952K | 1.59M | 1.59M | 1.59M | 1.14M | 506K | 506K | 506K | -9K | -41K | -100K | -150K | -176K | -144K | -85K | -35K |
Operating Income | -236.05M | -193.25M | -167.17M | -145.28M | -117.24M | -101.87M | -102.01M | -108.56M | -112.05M | -105.14M | -90.9M | -73.91M | -55.91M | -46.71M | -34.4M | -60.38M | -57.16M | -54.49M |
Interest Income | 24.65M | 23.43M | 20.71M | 16.01M | 13.41M | 10.54M | 7.98M | 6.91M | 5.32M | 3.35M | 1.75M | 862K | 300K | 39K | 15K | 11K | 6K | 5K |
Pretax Income | -218.28M | -175.46M | -152.15M | -134.38M | -107.85M | -94.3M | -95.99M | -102.77M | -107.35M | -102.04M | -89.06M | -73.46M | -56.4M | -44.98M | -32.61M | -58.64M | -55.48M | -55.65M |
Net Income | -218.28M | -175.46M | -152.15M | -134.38M | -107.85M | -94.3M | -95.67M | -102.46M | -106.47M | -101.16M | -88.56M | -72.96M | -56.46M | -45.04M | -32.61M | -58.64M | -55.49M | -55.65M |
Selling & General & Admin | 62.47M | 49M | 40.48M | 30.63M | 26.79M | 24.5M | 23.26M | 24.45M | 24.38M | 23.59M | 21.91M | 18.84M | 16.94M | 14.61M | 11.92M | 9.22M | 6.19M | 4.79M |
Research & Development | 173.01M | 144.25M | 127.64M | 116.25M | 92.03M | 78.95M | 79.39M | 84.11M | 87.67M | 81.55M | 68.99M | 55.07M | 38.98M | 32.1M | 22.48M | 49.58M | 47.98M | 46.7M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 1.19M | 1.19M | 1.19M | 1.19M | n/a | n/a | n/a | n/a | n/a | -301K | -301K | -301K |
Operating Expenses | 235.49M | 193.25M | 168.12M | 146.87M | 118.83M | 103.45M | 102.65M | 108.56M | 112.05M | 105.14M | 90.9M | 73.91M | 55.91M | 46.71M | 34.4M | 58.8M | 54.17M | 51.49M |
Interest Expense | 7.47M | 7.51M | 7.63M | 6.81M | 5.82M | 4.82M | 3.79M | 3.33M | 2.53M | 1.75M | 992K | 413K | 266K | 138K | 20K | 15K | 79K | 142K |
Selling & Marketing Expenses | n/a | n/a | -517K | -1.05M | -1.05M | -1.05M | -532K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 236.05M | 193.25M | 167.17M | 145.28M | 117.24M | 101.87M | 102.01M | 108.56M | 112.05M | 105.14M | 90.9M | 73.91M | 55.91M | 46.71M | 34.4M | 58.8M | 54.17M | 51.49M |
Income Tax Expense | 1K | 1K | 1K | 1K | 1K | 1K | -314K | -314K | -879K | -879K | -500K | -500K | 65K | 65K | -1K | 2.22M | 2.22M | 2.22M |
Shares Outstanding (Basic) | 63.79M | 63.67M | 54.9M | 54.9M | 54.73M | 50.97M | 44.45M | 44.36M | 44.27M | 37.67M | 27.8M | 27.22M | 27.08M | 24.23M | 21.28M | 21.27M | 20.87M | 20.48M |
Shares Outstanding (Diluted) | 63.79M | 63.67M | 54.9M | 54.9M | 54.73M | 50.97M | 44.45M | 44.36M | 44.27M | 37.67M | 27.8M | 27.22M | 27.08M | 24.23M | 21.28M | 21.27M | 20.87M | 20.48M |
EPS (Basic) | -3.71 | -3.13 | -2.88 | -2.61 | -2.21 | -2.05 | -2.28 | -2.87 | -3.31 | -3.4 | -3.32 | -2.94 | -2.41 | -2.02 | -1.54 | -2.84 | -3.57 | -4.29 |
EPS (Diluted) | -3.71 | -3.13 | -2.88 | -2.61 | -2.21 | -2.05 | -2.28 | -2.87 | -3.31 | -3.4 | -3.32 | -2.94 | -2.41 | -2.02 | -1.54 | -2.84 | -3.57 | -4.29 |
EBITDA | -217.46M | -175.16M | -145.4M | -131.06M | -108.14M | -95.59M | -97.87M | -102.54M | -106.03M | -101.84M | -89.1M | -74.05M | -56.36M | -44.69M | -32.41M | -58.48M | -55.32M | -55.36M |
EBIT | -218.1M | -175.24M | -144.52M | -129.5M | -103.96M | -91.41M | -94.13M | -99.44M | -104.81M | -100.29M | -88.06M | -73.05M | -56.13M | -44.84M | -32.59M | -58.62M | -55.41M | -55.51M |
Depreciation & Amortization | 727K | 1.66M | 622K | -68K | -1.53M | -4M | -3.55M | -3.52M | -2.23M | -1.36M | -846K | -217K | -6K | 150K | 176K | -498K | 116K | 178K |